About 87,200 results
Open links in new tab
FDA approves Novartis Kisqali® to reduce risk of recurrence in …
Novartis Kisqali® shows deepening benefit in new analysis, …
Novartis’ Kisqali receives FDA approval to reduce the risk of breast ...
FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer
FDA approves ribociclib with an aromatase inhibitor and ribociclib …
Novartis Wins FDA Approval of Kisqali for Early Breast Cancer
FDA approves Novartis Kisqali® to reduce risk of recurrence in …
Latest analysis of Novartis NATALEE study shows Kisqali® …
Kisqali Plus Hormone Therapy for Metastatic Breast Cancer
FDA Approves Ribociclib for Early Breast Cancer Treatment With …